
In a bid to reduce Ireland's smoking rate, Fine Gael health spokesperson Colm Burke has called for the age limit to purchase tobacco products to be raised to 21. Burke believes that this decisive action is necessary for Ireland to achieve its public health target of a less than 5 per cent smoking rate by 2025, a goal he considers at risk without effective measures.
Burke cited past successful smoking control methods in Ireland such as the 2004 ban on workplace smoking and standardised packaging introduced in 2014. However, he expressed concern about the diminishing momentum behind anti-smoking campaigns in recent years, especially with the rising popularity of vaping as a smoking gateway.
Asserting the need for government intervention, Burke said, "The most effective measure would be to raise the age for the purchase of tobacco products from 18 to 21. Evidence from the United States indicates a drop in smoking rates of 20 per cent and higher in the under 25 age group when the age limit is raised to 21 years."
Burke suggested that this could be accomplished through a government amendment to the Public Health [Tobacco and Nicotine Inhaling Products] Bill currently in the legislative process. Alternatively, a distinct legislative piece could amend the existing tobacco control legislation – the Public Health [Tobacco] Act 2002.
Backing his proposition, Burke referenced a 2022 report by the Royal College of Physicians that supports the age limit increase. This report highlights smoking as a factor in 4,500 deaths each year, placing a massive cost burden on the health system. Furthermore, it indicates that abstaining from smoking contributes to better health as people age, promoting longevity.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.





